Skip to main content
. 2022 Mar 21;9(5):622–632. doi: 10.1002/acn3.51542

Figure 2.

Figure 2

In cohort 1, serum (A) NfL, (B) ALC, (C) CRP, and (D) LDH levels were compared across HC versus COVID‐19 disease severity and multiple sclerosis disease activity subgroups using Kruskal–Wallis ANOVA; **p < 0.005 and ****p < 0.0001. The dotted line on each plot indicates the median of HC. NfL, neurofilament light chain; ALC, absolute lymphocyte count; CRP, C‐reactive protein; LDH, lactate dehydrogenase; COVID‐19, coronavirus disease 19; HC, healthy controls. [Colour figure can be viewed at wileyonlinelibrary.com]